© 2021 BioMarin. All rights reserved.

We take pride in manufacturing complex therapies for the patients who need them most.

BioMarin Technical Operations (TOPS) is an experienced, responsive and agile organisation with a proud connection to our patients – developing and manufacturing safe and effective medicines that we consistently deliver to those in need.

From enzyme to gene therapy, our owned manufacturing approach allows us to maintain the highest quality standards, along with the efficient production and delivery capability to meet clinical and commercial demands.

Our facilities include three cGMP (current Good Manufacturing Practices) manufacturing plants across Novato, California, and Shanbally, Ireland. The facilities offer dedicated cGMP process manufacturing, quality control, and research and development laboratory space.

Pioneers in Gene Therapy Manufacturing

At the forefront of one of the newest advancing fields in biotechnology, we built one of the first gene therapy manufacturing facilities of its kind, spanning 18,000 feet with the ability to produce up to 10,000 doses per year. In 2018, the International Society for Pharmaceutical Engineering (ISPE) selected our facility from 30 sites across the globe as the winner of the Facility of the Year Award® in the Project Execution Category. Projects selected in this category exemplify the application of novel tools and approaches to improve efficiencies and effectively overcome challenges.

EU/GTH/0022 March 2021

Our Pipeline

We take on the biggest challenges in rare disease.

Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition we hope to address.

Learn More Our Pipeline